检索结果 - Colleen Mockbee

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model

    Efficacy of delayed administration of sargramostim up to 120 hours post exposure in a nonhuman primate total body radiation model 由 Yifei Zhong, Mylène Pouliot, Anne-Marie Downey, Colleen Mockbee, Debasish Roychowdhury, W Wierzbicki, Simon Authier

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation

    Sargramostim (rhu GM-CSF) Improves Survival of Non-Human Primates with Severe Bone Marrow Suppression after Acute, High-Dose, Whole-Body Irradiation 由 Nicholas P. Clayton, Richard Khan-Malek, Charles A. Dangler, Donghui Zhang, Alexis Ascah, Malcolm Gains, Brent Gardner, Colleen Mockbee, Joan Keutzer, J McManus, Simon Authier

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer 由 Siqing Fu, Bradley R. Corr, Kerry Culm-Merdek, Colleen Mockbee, Hagop Youssoufian, Robert Stagg, R. Wendel Naumann, Robert M. Wenham, Rafael D. Rosengarten, Laura E. Benjamin, Erika Hamilton, Kathleen N. Moore

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer

    Preclinical Activity of Abemaciclib Alone or in Combination with Antimitotic and Targeted Therapies in Breast Cancer 由 Neil A. O’Brien, Dylan Conklin, Richard P. Beckmann, Tong Luo, Kevin Chau, Josh D. Thomas, Ann Mc Nulty, Christophe C. Marchal, Ondrej Kalous, Erika von Euw, Sara A. Hurvitz, Colleen Mockbee, Dennis J. Slamon

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial

    The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial 由 David Hsiehchen, Muhammad S. Beg, Radhika Kainthla, Jay Lohrey, Syed Mohammad Ali Kazmi, Leticia Khosama, Mary Claire Maxwell, Heather Kline, Courtney Katz, Asim Hassan, Naoto Kubota, E. Siglinsky, Anil K. Pillai, Hagop Youssoufian, Colleen Mockbee, Kerry Culm, Mark Uhlik, Laura E. Benjamin, Rolf A. Brekken, Chul Ahn, Amit G. Singal, Hao Zhu, Yujin Hoshida, Adam C. Yopp

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: